Friday, 12 April 2002


E. Schröder (Yvoir, Belgium)
C. Hanet (Brussels, Belgium)

Prevention of restenosis after coronary angioplasty

Session I

Abstract no
Chair E. Schröder (Yvoir, Belgium)
C. Hanet (Brussels, Belgium)
9.30 – 9.55 The clinical impact of restenosis
E. Schröder (Yvoir, Belgium)
9.55 – 10.20 Overview of randomized trials on prevention of restenosis by systemic drugs
C. Hanet (Brussels, Belgium)
10.20 – 10.45 Stent implantation during PTCA : a first step towards a reduction of restenotic events
V. Legrand (Liège, Belgium)
10.45 – 11.15 coffee break  
11.15 – 11.40 Brachytherapy in de novo and restenotic lesions
V. Verine (Genève, Switzerland)
11.40 – 12.05 Cytochalasin D inhibits neointimal formation in a porcine coronary stent model
K.J. Salu
, J.M. Bosmans, H. Bult, Y. Huang, L. Xiaoshun, I. K.  De Scheerder, and C.J. Vrints (Antwerp/Leuven, Belgium)
12.05 – 12.30 Drug eluting stents : a definitive solution for restenosis ?
Y. De Scheerder (Leuven, Belgium)
12.30    end of workshop 16